Artificial Intelligence, Part 1: Bias, Access, ROI, Potential Success and Failure
Podcast: BioSpacePublished On: Thu Nov 16 2023
Description: This is part one of a discussion focused upon data bias, accuracy, access and the future of AI in drug development. Topics explored are ROI, human bias, data challenges, data management plans, and human expertise. Host Lori Ellis, Head of Insights, BioSpace Guests Paul Agapow, Director of Innovation, Data Science and Strategy, GlaxoSmithKlineMike King, Senior Director of Product and Strategy, IQVIA Nindhana Paranthaman, Executive Medical Director, Exelixis Moritz von Stosch, Chief Information Officer, DataHow
The note was deleted
The note was saved
Your message was sent